Cargando…

Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older

PURPOSE: To assess the safety and outcomes of radiotherapy (RT) or chemoradiotherapy (CRT) in elderly patients (≥70) with rectal cancer. METHODS: Elderly patients aged 70 and older with rectal cancer, who were treated with RT or CRT at a single institution, were retrospectively analyzed. Performance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Xin, Wu, Hongbin, Peng, Junjie, Zhu, Ji, Cai, Sanjun, Cai, Gang, Zhang, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641029/ https://www.ncbi.nlm.nih.gov/pubmed/23574985 http://dx.doi.org/10.1186/1748-717X-8-86

Ejemplares similares

Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?
por: Peng, Junjie, et al.
Publicado: (2013)

Neoadjuvant chemoradiotherapy or radiotherapy in patients aged 75 years or older with locally advanced rectal cancer
por: Liu, Xiaoliang, et al.
Publicado: (2020)

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma
por: Zhu, Ji, et al.
Publicado: (2013)

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study
por: Zhu, Ji, et al.
Publicado: (2014)

Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
por: Li, Qingguo, et al.
Publicado: (2015)

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients
por: Zhu, Ji, et al.
Publicado: (2010)

Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
por: Wang, Yaqi, et al.
Publicado: (2022)

Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma
por: Zhu, Ji, et al.
Publicado: (2013)

Prognostic Nomograms for Predicting Survival and Distant Metastases in Locally Advanced Rectal Cancers
por: Peng, Junjie, et al.
Publicado: (2014)

Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
por: Metcalfe, Evrim, et al.
Publicado: (2016)

Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy
por: Li, Qingguo, et al.
Publicado: (2014)

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
por: Wang, Jingwen, et al.
Publicado: (2019)

Laparoscopic versus open surgical management in elderly patients with rectal cancer aged 70 and older
por: Li, Xiaolong, et al.
Publicado: (2023)

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer
por: Cai, Gang, et al.
Publicado: (2015)

The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
por: Jin, Ya-Nan, et al.
Publicado: (2019)

Lymph Node Count After Preoperative Radiotherapy Is an Independently Prognostic Factor For Pathologically Lymph Node-Negative Patients With Rectal Cancer
por: Li, Qingguo, et al.
Publicado: (2015)

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer
por: De Felice, Francesca, et al.
Publicado: (2013)

Recognition of Anterior Peritoneal Reflections and Their Relationship With Rectal Tumors Using Rectal Magnetic Resonance Imaging
por: Yiqun, Sun, et al.
Publicado: (2016)

Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study
por: Cai, Gang, et al.
Publicado: (2014)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study
por: Wang, Yaqi, et al.
Publicado: (2021)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

Elderly nasopharyngeal carcinoma patients (aged ≥70 years): Survival and treatment strategies
por: Yang, Gang, et al.
Publicado: (2023)

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype
por: Guan, Yun, et al.
Publicado: (2019)

Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older
por: Wan, Jue-feng, et al.
Publicado: (2015)

Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation
por: Tong, Tong, et al.
Publicado: (2015)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
por: Wang, Jian, et al.
Publicado: (2021)

Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
por: Wang, Xin, et al.
Publicado: (2023)

Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer
por: Imano, Nobuki, et al.
Publicado: (2020)

Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29
por: Peng, Junjie, et al.
Publicado: (2011)

Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?
por: Glimelius, Bengt
Publicado: (2014)

Definitive carbon ion re-irradiation with pencil beam scanning in the treatment of unresectable locally recurrent rectal cancer
por: Cai, Xin, et al.
Publicado: (2023)

The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision
por: Chen, Yikuan, et al.
Publicado: (2022)

Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
por: Wang, Weiping, et al.
Publicado: (2017)

Characteristics and Prognostic Significance of Preoperative Magnetic Resonance Imaging-Assessed Circumferential Margin in Rectal Cancer
por: Ma, Xiaoji, et al.
Publicado: (2015)

Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer
por: Wang, Hongmiao, et al.
Publicado: (2022)

Apparent Diffusion Coefficient (ADC) Value: A Potential Imaging Biomarker That Reflects the Biological Features of Rectal Cancer
por: Sun, Yiqun, et al.
Publicado: (2014)

A Retrospective Analysis on Two-week Short-course Pre-operative Radiotherapy in Elderly Patients with Resectable Locally Advanced Rectal Cancer
por: Shi, Chen, et al.
Publicado: (2016)

Surgical and oncological score to estimate the survival benefit of resection and chemoradiotherapy in elderly (≥70 years) glioblastoma patients: A preliminary analysis
por: Zorman, Mark J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0uh8m9mssb8hdshnbvta0iv62c